Zimmer Durom Cup Hip Replacement

Motley Rice is currently reviewing Zimmer Durom® cup hip replacement cases in which recipients of the Zimmer Durom cup have suffered intense pain or injuries following hip replacement surgery and have undergone or are scheduled to undergo a revision procedure. 

If you or someone you know has experienced severe pain or other injuries after the implantation of a Zimmer Durom hip replacement device, contact attorney John Duane by email or call 1.800.768.4026.

Durom Cup Lawsuits

While Zimmer maintains that its Durom device implant was not the cause of the many alleged losses, damages and injuries, some reports have indicated that the Durom cup may fail to fuse properly with the bone and instead, separate and migrate into the body. These reports state that when the Durom cup moves, it pushes the metal hip socket against the bone, which can cause excruciating pain for patients. Additionally, problems with the Durom cup may require patients to undergo hip revision surgeries, medical monitoring or rehabilitation. 

According to the New York Times, veteran orthopedic surgeon Dr. Lawrence Dorr first told Zimmer about his concerns with the Durom hip replacement cup in early 2008. The manufacturer did not investigate the issue, however, until Dr. Dorr raised his concerns with the American Association of Hip and Knee Surgeons. Zimmer subsequently suspended sales of the Durom cup in 2009, indicating that up to 5.7% of the implanted Durom cups may need to be replaced in the United States and Europe. Since 2006, the Durom cup had been implanted in nearly 13,000 patients. 

On June 9, 2010, the United States Judicial Panel on Multidistrict Litigation issued an order approving centralization of all Zimmer Durom cup hip device cases in the District of New Jersey under the Honorable Susan D. Wigenton. 

Ongoing Concerns with Metal-on-Metal Hip Implants

There has been controversy surrounding whether the benefit of metal hip implants outweighs the potential risks. In June 2012, the FDA held a two-day advisory panel meeting to discuss how to monitor the more than half-million U.S. patients with metal hip replacements given the results of recent studies and the thousands of adverse reports the FDA has received in connection to the devices. 

Following the meeting, the FDA began providing updated safety material on metal-on-metal hip replacements to both patients and health care providers. Additionally, the FDA will continue to review data on MoM devices currently on the market.